Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    CUBIST PHARMS INC

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2CUBIST PHARMS LLC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    CUBIST PHARMS LLC

    CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

    arrow
    PCHi
    Not Confirmed

    CUBIST PHARMS LLC

    Switzerland
    arrow
    PCHi
    Not Confirmed

    Patent Expiration Date : 2034-03-14

    CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

    US Patent Number : 11278622

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 206829

    Patent Use Code : U-3336

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-03-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    CUBIST PHARMS LLC

    CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

    arrow
    PCHi
    Not Confirmed

    CUBIST PHARMS LLC

    Switzerland
    arrow
    PCHi
    Not Confirmed

    Patent Expiration Date : 2034-03-14

    CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

    US Patent Number : 11278622

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 206829

    Patent Use Code : U-3335

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-03-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.